Literature DB >> 1615664

Ovarian cancer screening.

C I Macri, P J DiSaia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1615664      PMCID： PMC1003363     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  4 in total

1.  Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer.

Authors:  V R Zurawski; K Sjovall; D A Schoenfeld; S F Broderick; P Hall; R C Bast; G Eklund; B Mattsson; R J Connor; P C Prorok
Journal:  Gynecol Oncol       Date:  1990-03       Impact factor: 5.482

2.  Comparison of serum CA 125, clinical impression, and ultrasound in the preoperative evaluation of ovarian masses.

Authors:  N J Finkler; B Benacerraf; P T Lavin; C Wojciechowski; R C Knapp
Journal:  Obstet Gynecol       Date:  1988-10       Impact factor: 7.661

3.  Screening in ovarian cancer.

Authors:  W T Creasman; P J DiSaia
Journal:  Am J Obstet Gynecol       Date:  1991-07       Impact factor: 8.661

4.  Evaluation of adnexal masses with transvaginal color ultrasound.

Authors:  A Kurjak; I Zalud; Z Alfirevic
Journal:  J Ultrasound Med       Date:  1991-06       Impact factor: 2.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.